Last reviewed · How we verify
Tyrosinemia type I
Approved treatments
- Orfadin · Cycle Pharmaceuticals Ltd.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Tyrosinemia type I patent landscape — cliff calendar, originator estates, attackable patents
- Tyrosinemia type I treatment landscape brief
- Tyrosinemia type I treatment updates RSS
Frequently asked questions about Tyrosinemia type I
What drugs treat Tyrosinemia type I?
Tracked treatments include Orfadin.
What is the treatment for Tyrosinemia type I?
Standard treatment for Tyrosinemia type I includes Orfadin. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Tyrosinemia type I patent cliff · Tyrosinemia type I CI report
- Treatment: Orfadin · Cycle Pharmaceuticals Ltd.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing